US drugmaker readies possible coronavirus vaccine for testing

The drugmaker Moderna has shipped a potential coronavirus vaccine for humans to US government researchers for testing.

Shares of the biotech company soar, a day after the company said it sent vials to the National Institute of Allergy and Infectious Diseases for early-stage testing in the United States.

More than 80,000 people have been infected globally from the viral outbreak that began late last year in China. A total of 35 cases have been reported in the United States.

More than 2,600 people have died from the virus in mainland China, including one US citizen.

Shares of Moderna Inc., based in Cambridge, Massachusetts, have jumped nearly 16% in premarket trading.

The stock started trading in late 2018 and set an all-time high price of $29.79 last April, according to FactSet.

— AP

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.